Lucero awarded 300 000 SEK Vinnova Innovative Startups Stage 1 grant to test and optimize prototype for 3D cell model handling.
Out of 934 applicants, Lucero was selected by Vinnova, Sweden’s Innovation Agency, as one of the recipients of the Innovative Startups Stage 1 grant. The grant is targeted towards early-stage startups that are based on innovative products and services and that show global growth potential. The money is meant to help startups develop their prototypes and business models, as well as create strategies to protect and commercialize their intellectual assets.
Lucero will use the money to fund a collaborative research project together with Dr. Stina Simonsson, Sahlgrenska University Hospital, and Dr. Caroline Adiels, Gothenburg University. The project will focus on testing cartilage organoids in our existing prototype, increasing throughput speed, microfluidic development, and laying the groundwork for our AI protocols.
Lucero is very excited to begin the project together with Vinnova, Dr. Simonsson, and Dr. Adiels and we expect the results to bring us one step closer to transitioning from our lab to testing in a pharmaceutical environment.
“We are really happy to be awarded the Innovative Startups grant. This money will fund a crucial part of our product and technology development and are honored to be recognized by Vinnova, together with many great startups. We are really excited about the potential of the project, and the benefits it could bring.” – Rich Zapata Rosas, co-founder of Lucero
The Lucero team would also like to congratulate our fellow Chalmers Ventures’ Accelerator portfolio companies, Wavi Analytics, Vividye, Compular, Envue Technologies, Eperoto, Nyctea Technologies for also being selected as grant recipients!
Read more about Vinnova’s Innovative Startups Stage 1 grant.
